Log in  First Connection?

Others Urological ConditionsArchives

Treatment Patterns for Metastatic Urothelial Carcinoma Across Eight Mexican Centers: The ALEBRIJE Study.

 Published on 18/07/2025 |  Original article (Full-text)  | BeasLozano, Evelyn Lilian MD, et al. | JCO global oncology

Metastatic urothelial carcinoma (mUC) poses a challenge to health care systems, given its treatment complexity and mortality. We aimed to describe the characteristics, treatment patterns, and survival outcomes of Mexican patients with mUC. METHODS: A retrospective study was conducted across eight centers...

Metabolic evaluation and disease characteristics of urolithiasis in children from 2020 to 2024: a retrospective single-center study at the national children's medical center

 Published on 11/07/2025 |  Original article (Full-text)  | Hu Lizhe et al. | BMC Pediatrics 2025; 25(1): 505

Over the past two decades, the incidence of pediatric urolithiasis has increased at an annual rate of 6% to 10%. While the prevalence of pediatric urolithiasis is relatively low in developed countries, it has significantly increased in some East Asian countries, reaching up to 30%. Although the overall...

A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study

 Published on 04/07/2025 |  Original article (Full-text)  | Shobana Anpalakhan ‡ et al. | Immunotherapy 2024; 16(14-15): 963-73

Anemia, mean corpuscular volume and red cell distribution width may have some effects on survival outcomes of metastatic renal cell carcinoma (mRCC) patients and are incorporated in a red blood cell (RBC)-based score. Its validity in prognostication of mRCC patients treated with second-line nivolumab...

Oncologists' and urologists' preferences for adjuvant therapy in renal cell carcinoma: a discrete-choice experiment

 Published on 27/06/2025 |  Original article (Full-text)  | Caroline Vass et al. | Future Oncology 2025; 21(7): 833-42

To quantify physicians' preferences for adjuvant renal cell carcinoma (RCC) treatments. A discrete-choice experiment was administered online to board-certified/eligible physicians. Physicians chose between pairs of hypothetical adjuvant therapies for a high-risk patient who had recently undergone a radical...

The first case of urosepsis caused by Corynebacterium aurimucosum in an immunocompetent patient

 Published on 20/06/2025 |  Original article (Full-text)  | Lucia Corich * et al. | Future Microbiology 2024; 19(11): 963-70

Non-diphtheroid Corynebacteriumsepsis is rare and has affected only immunocompromised or particularly predisposed patients so far. We present the first case of urosepsis caused by Corynebacterium aurimucosumin a 67-year-old woman, without any known immunodeficiencies and in absence...